Passage Bio, Inc. (PASG)
NASDAQ: PASG · Real-Time Price · USD
0.3860
+0.0329 (9.32%)
At close: Apr 1, 2025, 4:00 PM
0.3837
-0.0023 (-0.60%)
After-hours: Apr 1, 2025, 5:30 PM EDT

Passage Bio Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2024 FY 2023 FY 2022 FY 2021 FY 2020 2019 - 2018
Period Ending
Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2019 - 2018
Net Income
-64.77-102.06-136.13-185.39-112.23
Upgrade
Depreciation & Amortization
3.083.723.681.540.8
Upgrade
Loss (Gain) From Sale of Assets
-0.46---
Upgrade
Asset Writedown & Restructuring Costs
5.235.39381
Upgrade
Loss (Gain) From Sale of Investments
-1.53-2.040.772.780.63
Upgrade
Stock-Based Compensation
5.8210.9218.9532.6914.58
Upgrade
Other Operating Activities
8.23--2.080.26
Upgrade
Change in Accounts Payable
-0.56-2.79-5.412.24.59
Upgrade
Change in Other Net Operating Assets
-3.478.13-3.089.229.85
Upgrade
Operating Cash Flow
-47.96-78.26-118.21-126.88-80.52
Upgrade
Capital Expenditures
-0.03-0.15-2.27-17.64-1.15
Upgrade
Sale (Purchase) of Intangibles
---3-8-0.5
Upgrade
Investment in Securities
54.9865.3830.47-20.17-170.46
Upgrade
Investing Cash Flow
54.9565.2425.2-45.81-172.11
Upgrade
Issuance of Common Stock
8.870.140.43166.99228.75
Upgrade
Other Financing Activities
---1.79-0.34-
Upgrade
Financing Cash Flow
8.870.14-1.35166.66228.75
Upgrade
Net Cash Flow
15.86-12.89-94.36-6.04-23.87
Upgrade
Free Cash Flow
-47.99-78.41-120.48-144.52-81.67
Upgrade
Free Cash Flow Per Share
-0.79-1.43-2.21-2.71-2.12
Upgrade
Levered Free Cash Flow
-27.55-48.22-76.01-91.09-44.18
Upgrade
Unlevered Free Cash Flow
-27.55-48.22-76.01-91.09-44.18
Upgrade
Change in Net Working Capital
-4.31-1.6612.56-11.4-12.03
Upgrade
Updated Mar 4, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q